Compounds > 1,2-bis(5-amidino-2-benzimidazolyl)ethane
Page last updated: 2024-09-04

1,2-bis(5-amidino-2-benzimidazolyl)ethane and Bright Disease

1,2-bis(5-amidino-2-benzimidazolyl)ethane has been researched along with Bright Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bing, DH; Falk, RJ; Geratz, JD; Jennette, JC; Tidwell, RR1

Other Studies

1 other study(ies) available for 1,2-bis(5-amidino-2-benzimidazolyl)ethane and Bright Disease

ArticleYear
Amelioration of immune complex-mediated glomerulonephritis by synthetic protease inhibitors.
    The American journal of pathology, 1987, Volume: 127, Issue:3

    Topics: Amidines; Animals; Benzimidazoles; Complement Inactivator Proteins; Creatinine; Glomerulonephritis; Hydroxamic Acids; Immune Complex Diseases; Indoles; Male; Mice; Protease Inhibitors; Time Factors; Trypsin Inhibitors

1987